<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/3809EB16-4A33-4BBA-8FCD-8C52A0983EB5" ns1:id="3809EB16-4A33-4BBA-8FCD-8C52A0983EB5"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/D534BA1D-01B0-440D-94E0-2EDA8A2888C9" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/B24E9CB6-4D73-41B9-849B-743D916BD703" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/B24E9CB6-4D73-41B9-849B-743D916BD703" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/610AB57F-83DB-455B-9FBD-0842A46A50C7" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2014-11-30T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/E9E34D35-7B30-4992-955E-352532970191" ns1:rel="FUND" ns1:start="2013-05-31T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">131170</ns2:identifier></ns2:identifiers><ns2:title>Use of Synthetically Engineered Bacteriophages for Antibacterial Therapy</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Feasibility Studies</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>This project aims to demonstrate the feasibility of utilising naturally occuring bacteria and phages as the basis of a novel Clostridium difficile (C.diff) therapy as an alternative to antibiotics.</ns2:abstractText></ns2:project>